Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV . [Carta]: a structured summary of a study protocol for a randomised controlled trial (2020)
- Authors:
- Autor USP: KALLAS, ESPER GEORGES - FM
- Unidade: FM
- DOI: 10.1186/s13063-020-04775-4
- Subjects: COVID-19; PANDEMIAS; VACINAS; VACINAÇÃO; ENVELHECIMENTO; INCIDÊNCIA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
PALACIOS, Ricardo et al. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV . [Carta]: a structured summary of a study protocol for a randomised controlled trial. Trials. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1186/s13063-020-04775-4. Acesso em: 06 jun. 2025. , 2020 -
APA
Palacios, R., Patino, E. G., Piorelli, R. de O., Conde, M. T. R. P., Batista, A. P., Zeng, G., et al. (2020). Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV . [Carta]: a structured summary of a study protocol for a randomised controlled trial. Trials. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1186/s13063-020-04775-4 -
NLM
Palacios R, Patino EG, Piorelli R de O, Conde MTRP, Batista AP, Zeng G, Xin Q, Kallas EG, Flores J, Ockenhouse CF. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV . [Carta]: a structured summary of a study protocol for a randomised controlled trial [Internet]. Trials. 2020 ; 21( 1):[citado 2025 jun. 06 ] Available from: https://doi.org/10.1186/s13063-020-04775-4 -
Vancouver
Palacios R, Patino EG, Piorelli R de O, Conde MTRP, Batista AP, Zeng G, Xin Q, Kallas EG, Flores J, Ockenhouse CF. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV . [Carta]: a structured summary of a study protocol for a randomised controlled trial [Internet]. Trials. 2020 ; 21( 1):[citado 2025 jun. 06 ] Available from: https://doi.org/10.1186/s13063-020-04775-4 - Skewed distribution of natural killer cells in psoriasis skin lesions [Carta]
- Patterns and Correlates of PrEP Drug Detection Among MSM and Transgender Women in the Global iPrEx Study
- Abnormal phenotypic distribution of regulatory and effector T cells in octogenarian and nonagenarian women
- Zika in the americas, year 2: what have we learned? What gaps remain? A report from the global virus network
- Ontogeny of the B- and T-cell response in a primary Zika virus infection of a dengue-naive individual during the 2016 outbreak in Miami, FL
- MAIT cells are activated in acute Dengue virus infection and after in vitro Zika virus infection
- Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay Platforms
- Generation of Zika virus - specific T cells from seropositive and virus-naive donors for potential use as an autologous or ""off-the-shelf"" immunotherapeutic
- HIV-1 genetic diversity and divergence and its correlation with disease progression among antiretroviral naive recently infected individuals
- Performance of HIV pre-exposure prophylaxis indirect adherence measures among men who have sex with men and transgender women: Results from the PrEP Brasil Study
Informações sobre o DOI: 10.1186/s13063-020-04775-4 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
